11,182 Shares in iShares Biotechnology ETF $IBB Bought by BNC Wealth Management LLC

BNC Wealth Management LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,182 shares of the financial services provider’s stock, valued at approximately $1,887,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter worth about $25,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $36,000. Parkside Financial Bank & Trust boosted its position in iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 87 shares during the last quarter. Close Asset Management Ltd grew its stake in iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after purchasing an additional 70 shares in the last quarter. Finally, Founders Financial Alliance LLC grew its stake in iShares Biotechnology ETF by 605.7% in the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 321 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $172.16 on Friday. The business has a 50 day moving average price of $170.19 and a two-hundred day moving average price of $165.75. iShares Biotechnology ETF has a twelve month low of $109.68 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.